Q. I developed severe depression while taking Repatha, the injectable cholesterol lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...
US companies Amgen, Bristol Myers Squibb, Gilead Sciences, and Merck/MSD have signed up to reduce the prices of medicines for ...
Zacks.com on MSN
BMY vs AMGN: Which Biotech Stock Is More Resilient Now?
From a price-performance perspective, BMY has fetched slightly better returns than AMGN in the past six months. Shares of ...
Merck's oral PCSK inhibitor for cholesterol, enlicitide, and its cancer antibody-drug conjugate sacituzumab tirumotecan (sac-TMT) will become the next two treatments to gain accelerated review through ...
President Trump’s anti-LGBTQ agenda dominated national news in 2025, particularly his cruel attacks on trans Americans. Here are our picks for the top 10 LGBTQ news stories the Blade covered in 2025.
Zacks.com on MSN
5 Big Drug Stocks That May Continue to Outperform in 2026
After a weak first half, the drug and biotech sector has recovered in the past 2-3 months, with most large drugmakers signing drug pricing agreements with the Trump administration. After a cautious ...
Zacks Investment Research on MSN
Novo Nordisk vs. Amgen: Which healthcare stock is the smarter choice?
Both Novo Nordisk NVO and Amgen AMGN are large-cap, innovation-driven healthcare leaders with global scale, strong balance ...
Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...
Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.
Therefore, the ideal candidates for a spinal injection are those with symptoms (sciatica) that are predominantly driven by ...
Hundreds of people watch as journalist Justin Nobel discusses the history of injection well legislation on Tuesday evening at Washington State College of Ohio. (Photo by Gwen Sour) MARIETTA — ...
LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga. The injected treatment, which will carry the commercial name Lerochol, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results